GENERAL28 Sept 2026
Zydus Lifesciences gains 2%, hits 52-week high in weak market; here's why
Zydus Lifesciences shares touched a 52-week high of ₹1,228.25 on Monday, even as the broader market stayed weak. That's a 47% jump from the stock's 52-week low of ₹835.85, seen on March 2, 2026. For business owners and taxpayers holding pharma stocks, it's a reminder that sharp recoveries do happen. Check your portfolio and capital gains position before acting.
Key Statutory Highlights
- Zydus Lifesciences share price hit a 52-week high of ₹1,228.25 in Monday's trading session.
- The stock bounced back 47% from its 52-week low of ₹835.85, which was touched on March 2, 2026.
- The rise came even as the overall market was weak that day.
Actionable Advice for Taxpayers / Founders:If you hold this stock, review your holding period and unrealised gains so you know your likely tax position, and speak to a tax professional before you sell.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: